Conjunctival and Scleral Avascular Lesions
📧 Sign up to get email alerts when something new happens for Conjunctival and Scleral Avascular Lesions.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: The Effect of Erythropoietin in the Treatment of Scleral Necrosis [Phase 2, Phase 3]
A phase 2/3 trial investigating erythropoietin for treating scleral necrosis (conjunctival and scleral avascular lesions).